FDA officially approves COVID-19 drug
On May 1, the US Food and Drug Administration (FDA) approved the emergency use of the experimental drug Remdesivira in the treatment of patients infected with coronavirus. Writes about this New York Post.
Research has shown that treatment with this antiviral drug can speed recovery in patients with COVID-19. US President Donald Trump made a joint statement with Dan O'Day, CEO of pharmaceutical company Gilead Sciences on the approval of the drug.
“I am pleased to announce that Gilead now has an emergency clearance from the FDA for Remdesivir.” And you know what that means, because it has been hot news in the media lately - this is an important treatment for hospitalized patients with coronavirus, ”Trump said.
He added that he spoke with members of the White House Coronavirus Group, Dr. Anthony Fauci, Deborah Birks and FDA CEO Stephen Khan, and they all agreed that this was a “promising situation.”
“We worked with teams at the FDA and NIH (National Institutes of Health), and Gilead now leads this public-private partnership to make things happen very quickly,” the president added.
“I think this really illustrates what can happen in such a short time. Less than 90 days have passed from the first case of coronavirus detection in the United States to today, our first step to using a therapeutic agent to treat it, ”said Birks.
A federal study found that treatment with Remdesivir could speed recovery in patients with COVID-19. The FDA solution expands access to the drug by allowing any doctor to prescribe Remdesivir to their patients with COVID-19.
But this does not mean that the drug is recommended for all hospitalized patients. Clinical trials are still ongoing to determine which patients will benefit most from Remdesivir treatment.
Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said Wednesday, April 29, that there is positive news regarding this drug.
Permission to use the drug in emergency situations is not the same as official approval of the drug by the agency.
When the federal government announces a public health emergency, the FDA can approve medicines to deal with the emergency if there is no alternative.
According to Fauci, the data showed that Remdesivir had a positive effect on accelerating the recovery time of patients.
Trump and Fauci welcomed the first results of the study, on the same day when the death toll in the United States exceeded 60.
“This is very important because it’s proven that the medicine can block this virus,” Fauci said. “It inspires hope.”
The study involved 1 patients who were given Remdesivir or placebo. Recovery time averaged 063 days for those who received the drug, compared to 11 days for those who received a placebo.
However, the FDA warned in its newsletter that the drug is still experimental.
“There is no FDA approved drug for the treatment of COVID-19. Taking Remdesivir may benefit certain hospitalized patients with COVID-19, ”the agency said in a statement.
The document also warns that people with certain diseases or conditions must inform them of their doctor before taking the drug. The list of these conditions includes allergies, problems with the kidneys or liver, pregnancy or breastfeeding, any serious diseases, taking other medications, vitamin or dietary supplements.
Adverse reactions to Remdesivir include lowering blood pressure, nausea, vomiting, sweating, and trembling.
As ForumDaily wrote earlier:
- According to patient-based data, more than two-thirds of seriously ill patients with COVID-19 condition improved after treatment with Remdesivir.
stdClass Object ([term_id] => 1 [name] => Miscellaneous [taxonomy] => category [slug] => no_theme)Miscellaneous
stdClass Object ([term_id] => 12 [name] => In the US [taxonomy] => category [slug] => novosti-ssha)In the U.S.
stdClass Object ([term_id] => 1375 [name] => treatment [taxonomy] => post_tag [slug] => lechenie)treatment
stdClass Object ([term_id] => 28340 [name] => coronavirus [taxonomy] => post_tag [slug] => koronavirus)coronavirus
stdClass Object ([term_id] => 28347 [name] => Special projects [taxonomy] => category [slug] => specproekty)Special Projects
stdClass Object ([term_id] => 28353 [name] => Coronavirus 2019-nCoV [taxonomy] => special [slug] => kitajskij-koronavirus)
Read also on ForumDaily:
Let's face the crisis together and support each other
No one in the world expected a coronavirus pandemic, but she came in disrupting the usual rhythm of life and work of billions of people, causing panic and uncertainty about tomorrow.
ForumDaily also faced financial difficulties due to the loss of some advertisers due to the economic downturn and quarantine. But we are not reducing the number of materials and the mode of operation, since we want our readers to receive timely and up-to-date information in this difficult time. In addition, we support Local small businesses in the USA that suffer the most.
But ForumDaily is also a small business. Despite the loss of part of the income, we are doing our best to ensure that you are informed and armed with all the necessary knowledge to counter the pandemic and resolve other important issues during quarantine.
To maintain this rhythm of work, we need your help. We will be grateful for any amount that you are willing to allot to support our team.
Let's face the crisis together!
Security of contributions is guaranteed by the use of the highly secure Stripe system.
Always yours, ForumDaily!
Do you want more important and interesting news about life in the USA and immigration to America? Subscribe to our page in Facebook. Choose the option "Priority in the show" - and read us first. And don't forget to subscribe to ForumDaily Woman and ForumDaily New York - there you will find a lot of interesting and positive information.